Aki Morikawa, MD

Aki Morikawa, MD, PhD
Specialty: Medical Oncology, Hematology, Internal Medicine
Title: Clinical Associate Professor
4.9/5
See All Ratings

To request an appointment call

734-647-8902
Aki Morikawa, MD
Aki Morikawa, MD, PhD
Medical Oncology
  • About
  • Areas of Practice
  • Expertise
  • Locations
  • Insurance
  • Education & Training
  • Research Overview

  • Manage Your Profile

    • About
    Dr. Morikawa joined the faculty in August 2014. After earning her M.Mus. in Piano Performance and M.PH in Epidemiology and Biostatistics from Boston University, Dr. Morikawa received her MD/Ph.D. at the Emory University School of Medicine. After completing her internal medicine residency training at Emory, she underwent fellowship training in Medical Oncology at Memorial Sloan Kettering Cancer Center. In 2014, she joined the faculty of the University of Michigan. She specializes in the care of patients with breast cancer at the Rogel Cancer Center. Her research involves clinical and translational investigations in breast cancer as well as brain and leptomeningeal metastases from solid tumors.

    Areas of Practice
    Breast cancer, clinical and translational research, central nervous system metastases from solid tumors, medical oncologist.

    Locations
    • Breast Oncology Clinic | Rogel Cancer Center 1500 E Medical Center Dr
      Floor 1
      Ann Arbor, MI 48109-5916       Get Directions

    Insurance Accepted

    University of Michigan Health participates with most health insurance plans.

    See our insurance details

    Education & Training

    Medical School or Training
    Emory University School of Medicine, 2008

    Residency
    Emory University, Internal Medicine, 2011

    Fellowships
    Memorial Sloan Kettering Cancer Center, Hematology/Medical Oncology, 2014

    Board Certifications
    Internal Medicine
    Medical Oncology

    Professional Organizations
    Society for Immunotherapy of Cancer
    Consortium for Intracranial Metastasis Academic Research
    European Society for Medical Oncology,
    The Society for Neuro-Oncology
    American Society of Clinical Oncology

    Research Overview

    1. New therapy for brain and leptomeningeal metastases from breast cancer

    2. Epidemiology and molecular profiling of central nervous system metastases from solid tumors

    3. Biomarker development for central nervous system metastasis from solid tumors

    4. Preclinical models to examine central nervous system metastasis from solid tumors

    5. New therapy for breast cancers.